Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Withdrawn 1Terminated 1

Sponsor Class

OTHER 2NETWORK 2INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other 2Other hematologic neoplasm 1Myeloid 1Lymphoid 1Head & Neck 1

Conditions

Mucositis 2Squamous Cell Carcinoma of Head and Neck 1Radiation Injuries 1Pain 1Neoplasms 1Head and Neck Neoplasms 1

Interventions

Fibroblast Growth Factor 7 2isatuximab 1Taxes 1Tadalafil 1Sildenafil Citrate 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Radiotherapy 1Psychiatric Rehabilitation 1Paclitaxel 1Neck Dissection 1Cisplatin 1Carboplatin 1Brachytherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Fibroblast Growth Factor 7 × Other × Clear all
NCT00728585 2018-08-07

Palifermin in Preventing Oral Mucositis Caused by Chemotherapy and/or Radiation Therapy in Young Patients Undergoing Stem Cell Transplant

Children's Oncology Group

Phase 2 Withdrawn
Other

Neoplasms, Mucositis

NCT00360971 2017-12-26

Palifermin in Lessening Oral Mucositis in Patients Undergoing Radiation Therapy and Chemotherapy for Locally Advanced Head and Neck Cancer

Radiation Therapy Oncology Group

Phase 3 Terminated
21 enrolled 10 charts
Head & NeckOther

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Pain, Radiation Injuries, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡